KHK & Partners
Overview
KHK & Partners is an independent financial services firm established in 2015 in the Dubai International Financial Centre. The firm is licensed and regulated as an Asset Manager by the Dubai Financial Services Authority. It focuses on sourcing, structuring, and managing investments on behalf of HNWIs, Family Groups, and Institutions, with a focus on global alternatives.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Syneron Bio | Dec 2025 | Series A | Co-investor |
| Syneron Bio | Dec 2025 | Series A | Co-investor |
| TandemAI | Nov 2025 | Series A Extension | Lead |
| Hangzhou Eli Radiopharma Co., Ltd. | Sep 2025 | Angel | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is KHK & Partners based?
KHK & Partners is headquartered in Dubai, Dubai, United Arab Emirates.
When was KHK & Partners founded?
KHK & Partners was founded in 2015.
How many portfolio companies does KHK & Partners have?
KHK & Partners has 5 portfolio companies in Caplight's dataset.
What are some companies in KHK & Partners's portfolio?
Recent investments visible on Caplight include Syneron Bio, Syneron Bio, TandemAI, TandemAI, Hangzhou Eli Radiopharma Co., Ltd..
What was KHK & Partners's most recent investment?
KHK & Partners's most recent investment on Caplight was in Syneron Bio in 2025.
What sectors does KHK & Partners focus on?
KHK & Partners focuses on Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure.
What company stages does KHK & Partners focus on?
KHK & Partners typically invests at the Early stage.
What is KHK & Partners's AUM?
KHK & Partners's assets under management are estimated between $100.0M and $250.0M.